N. Majidova, “Efficacy of Second-Line Treatments After Atezolizumab and Bevacizumab in Advanced Hepatocellular Carcinoma and Related Prognostic Factors: A Multicenter Study by the Turkish Oncology Group (TOG)”, Turkish Journal of Gastroenterology, vol. 36, no. 5, pp. 293–301, Apr. 2025.